A bipartisan group of U.S. senators yesterday urged the Federal Trade Commission to investigate possible illegal collusion by saline solution manufacturers.
The Health Resources and Services Administration’s (HRSA) proposed omnibus guidance for the 340B Drug Pricing Program would jeopardize hospitals’ ability to serve vulnerable populations
The Centers for Medicare & Medicaid Services today posted the final incentive payment adjustment factors for the fiscal year 2016 Hospital Value-Based Purchasing Program, which are being used t
Congress should preserve the 340B Drug Pricing Program to protect access to life-saving medications and services for vulnerable hospital patients, AHA President and CEO Rick Pollack writes today in
Health care providers, technology vendors and the government must work together to make health information easier and less expensive to share, writes Mitzi Cardenas, chief information officer for T
Congress returned to Capitol Hill this week facing uncertainty over who the next Speaker of the House will be and a looming deadline for action on its statutory debt ceiling.